Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taste Profile of Vericiguat Oral Suspension in Healthy Men
NCT06474208Phase 1Completed
- Sponsor
- Bayer
- Start
- Jul 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of Vericiguat oral suspension (Formulation 4) in heart failure (HF) (5 arms), sponsored by Bayer. Primary endpoint: Taste questionnaire by means of descriptive statistics. Started Jul 2024; status: completed.
02
Drugs
Vericiguat oral suspension (Formulation 4)
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06474208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06474208.